Found: 16
Select item for more details and to access through your institution.
Improving evidence developed from population-level experience with targeted agents.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 478, doi. 10.1002/cpt.90
- By:
- Publication type:
- Article
ALCHEMIST: Bringing genomic discovery and targeted therapies to early-stage lung cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 447, doi. 10.1002/cpt.91
- By:
- Publication type:
- Article
Incorporating exposure-response modeling into the assessment of QTc interval: A potential alternative to the thorough QT study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 444, doi. 10.1002/cpt.92
- By:
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 433, doi. 10.1002/cpt.95
- Publication type:
- Article
Oncology trial design: More accurately and efficiently advancing the field.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 430, doi. 10.1002/cpt.94
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 429, doi. 10.1002/cpt.96
- Publication type:
- Article
Bruton's tyrosine kinase inhibitors in B-cell non-Hodgkin's lymphomas.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 469, doi. 10.1002/cpt.65
- By:
- Publication type:
- Article
ASCPT NEWS.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 435, doi. 10.1002/cpt.97
- Publication type:
- Article
Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 508, doi. 10.1002/cpt.81
- By:
- Publication type:
- Article
Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 451, doi. 10.1002/cpt.82
- By:
- Publication type:
- Article
The growing number of hemophilia registries: Quantity vs. quality.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 492, doi. 10.1002/cpt.83
- By:
- Publication type:
- Article
Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 455, doi. 10.1002/cpt.85
- By:
- Publication type:
- Article
The role of nonrandomized trials in the evaluation of oncology drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 502, doi. 10.1002/cpt.86
- By:
- Publication type:
- Article
Rational use of medicines in older adults: Can we do better during clinical development?
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 440, doi. 10.1002/cpt.87
- By:
- Publication type:
- Article
Innovative Clinical Trials: The LUNG-MAP Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 488, doi. 10.1002/cpt.88
- By:
- Publication type:
- Article
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
- Published in:
- Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 5, p. 518, doi. 10.1002/cpt.89
- By:
- Publication type:
- Article